ShockWave Medical Quarterly Balance Sheets Chart
Quarterly
|
Annual
ShockWave Medical Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||
| current assets: | ||||||||||||||||||||
| cash and cash equivalents | 328,422,000 | 498,108,000 | 141,458,000 | 280,932,000 | 156,586,000 | 127,779,000 | 99,913,000 | 66,252,000 | 89,209,000 | 91,195,000 | 84,268,000 | 57,006,000 | 50,423,000 | 215,256,000 | 218,296,000 | 123,111,000 | 139,045,000 | 39,452,000 | 41,924,000 | 138,064,000 |
| short-term investments | 662,132,000 | 419,225,000 | 117,131,000 | 135,929,000 | 147,907,000 | 122,888,000 | 124,993,000 | 134,875,000 | 111,772,000 | 91,759,000 | 90,478,000 | 120,422,000 | 151,931,000 | 13,109,000 | 47,278,000 | 56,304,000 | 74,646,000 | 83,213,000 | ||
| accounts receivable | 114,552,000 | 98,819,000 | 96,562,000 | 84,309,000 | 71,366,000 | 64,224,000 | 59,797,000 | 47,842,000 | 37,435,000 | 29,966,000 | 24,955,000 | 19,613,000 | 11,689,000 | 10,711,000 | 6,365,000 | 7,811,000 | 7,377,000 | 5,551,000 | 5,242,000 | 3,939,000 |
| inventory | 107,587,000 | 97,180,000 | 92,093,000 | 83,256,000 | 75,112,000 | 68,974,000 | 60,028,000 | 53,369,000 | 42,978,000 | 38,744,000 | 36,149,000 | 33,538,000 | 29,859,000 | 28,868,000 | 23,427,000 | 15,921,000 | 12,074,000 | 9,227,000 | 8,291,000 | 7,014,000 |
| prepaid expenses and other current assets | 12,567,000 | 15,210,000 | 9,118,000 | 6,399,000 | 8,292,000 | 11,393,000 | 7,275,000 | 7,572,000 | 4,508,000 | 4,364,000 | 3,781,000 | 2,533,000 | 2,398,000 | 3,033,000 | 3,117,000 | 3,485,000 | 1,897,000 | 2,199,000 | 1,953,000 | 2,508,000 |
| total current assets | 1,225,260,000 | 1,128,542,000 | 456,362,000 | 590,825,000 | 459,263,000 | 395,258,000 | 352,006,000 | 309,910,000 | 285,902,000 | 256,028,000 | 239,631,000 | 233,112,000 | 246,300,000 | 257,868,000 | 264,314,000 | 197,606,000 | 216,697,000 | 131,075,000 | 140,623,000 | 151,525,000 |
| operating lease right-of-use assets | 29,707,000 | 30,360,000 | 31,117,000 | 31,623,000 | 32,365,000 | 33,107,000 | 26,045,000 | 26,729,000 | 27,496,000 | 11,790,000 | 6,825,000 | 7,211,000 | 7,568,000 | 7,841,000 | 8,130,000 | 8,495,000 | 8,825,000 | 2,155,000 | 2,398,000 | 2,645,000 |
| property and equipment | 68,923,000 | 62,017,000 | 59,803,000 | 54,057,000 | 48,152,000 | 39,265,000 | 32,253,000 | 27,886,000 | 24,361,000 | 23,085,000 | 21,467,000 | 20,233,000 | 16,362,000 | 13,282,000 | 13,287,000 | 13,084,000 | 4,910,000 | 4,111,000 | 3,244,000 | 2,803,000 |
| equity method investment | 1,643,000 | 1,810,000 | 2,543,000 | 2,689,000 | 3,512,000 | 4,573,000 | 4,476,000 | 5,940,000 | 5,987,000 | 6,408,000 | 6,750,000 | 6,750,000 | ||||||||
| intangible assets | 92,857,000 | 93,775,000 | 94,692,000 | |||||||||||||||||
| goodwill | 39,568,000 | 39,789,000 | 39,789,000 | |||||||||||||||||
| deferred tax assets | 99,169,000 | 109,432,000 | 94,699,000 | 97,941,000 | 97,568,000 | |||||||||||||||
| other assets | 9,436,000 | 8,234,000 | 7,599,000 | 6,112,000 | 5,229,000 | 3,606,000 | 2,365,000 | 2,055,000 | 1,936,000 | 1,684,000 | 1,686,000 | 1,764,000 | 1,812,000 | 1,667,000 | 1,622,000 | 1,553,000 | 1,506,000 | 548,000 | 542,000 | 566,000 |
| total assets | 1,566,563,000 | 1,473,959,000 | 786,604,000 | 783,247,000 | 646,089,000 | 475,809,000 | 417,145,000 | 372,520,000 | 345,682,000 | 298,995,000 | 276,359,000 | 269,070,000 | 272,042,000 | 280,658,000 | 287,353,000 | 220,738,000 | 231,938,000 | 137,889,000 | 146,807,000 | 157,539,000 |
| liabilities and stockholders’ equity | ||||||||||||||||||||
| current liabilities: | ||||||||||||||||||||
| accounts payable | 8,868,000 | 6,870,000 | 12,869,000 | 11,050,000 | 6,721,000 | 3,469,000 | 5,266,000 | 8,467,000 | 3,520,000 | 3,632,000 | 2,633,000 | 3,728,000 | 1,466,000 | 1,972,000 | 2,562,000 | 2,150,000 | 2,790,000 | 2,486,000 | 2,216,000 | 3,967,000 |
| accrued liabilities | 91,696,000 | 69,764,000 | 65,769,000 | 49,640,000 | 55,375,000 | 49,492,000 | 47,253,000 | 33,019,000 | 40,870,000 | 33,017,000 | 28,317,000 | 23,918,000 | 19,942,000 | 16,662,000 | 14,381,000 | 15,826,000 | 13,777,000 | 9,496,000 | 7,378,000 | 6,439,000 |
| lease liability, current portion | 3,641,000 | 1,569,000 | 1,582,000 | 1,308,000 | 1,278,000 | 1,260,000 | 2,688,000 | 1,294,000 | 1,738,000 | 867,000 | 920,000 | 898,000 | 873,000 | 841,000 | 798,000 | 787,000 | 774,000 | 742,000 | 806,000 | 877,000 |
| total current liabilities | 104,205,000 | 78,203,000 | 80,220,000 | 141,998,000 | 63,374,000 | 54,221,000 | 66,207,000 | 51,030,000 | 51,628,000 | 40,266,000 | 35,995,000 | 33,494,000 | 25,581,000 | 21,125,000 | 17,741,000 | 18,763,000 | 24,008,000 | 19,391,000 | 15,400,000 | 14,616,000 |
| lease liability, noncurrent portion | 35,103,000 | 32,358,000 | 33,205,000 | 34,058,000 | 34,928,000 | 38,532,000 | 27,157,000 | 32,361,000 | 28,321,000 | 11,939,000 | 6,911,000 | 7,213,000 | 7,488,000 | 7,685,000 | 7,903,000 | 8,077,000 | 8,125,000 | 1,543,000 | 1,732,000 | 1,916,000 |
| convertible debt, noncurrent portion | 731,863,000 | 730,926,000 | ||||||||||||||||||
| debt, noncurrent portion | 24,266,000 | 24,231,000 | 24,198,000 | |||||||||||||||||
| related party contract liability, noncurrent portion | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | 12,273,000 | ||||||||
| deferred tax liabilities | 3,609,000 | 9,647,000 | 10,421,000 | |||||||||||||||||
| long-term income tax liability | 1,526,000 | |||||||||||||||||||
| other liabilities | 9,307,000 | 9,307,000 | 9,307,000 | |||||||||||||||||
| total liabilities | 897,886,000 | 872,714,000 | 169,692,000 | 212,560,000 | 134,773,000 | 119,879,000 | 112,077,000 | 104,697,000 | 103,852,000 | 78,704,000 | 68,012,000 | 64,816,000 | 46,388,000 | 43,611,000 | 41,930,000 | 42,966,000 | 39,285,000 | 29,639,000 | 27,394,000 | 28,353,000 |
| commitments and contingencies | ||||||||||||||||||||
| stockholders’ equity: | ||||||||||||||||||||
| preferred stock, 0.001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of december 31, 2023 and 2022 | ||||||||||||||||||||
| common stock | 37,000 | 37,000 | 37,000 | 37,000 | 36,000 | 36,000 | 36,000 | 36,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | 34,000 | 34,000 | 32,000 | 31,000 | 28,000 | 28,000 | 28,000 |
| additional paid-in capital | 557,882,000 | 535,197,000 | 586,092,000 | 568,705,000 | 548,960,000 | 535,230,000 | 519,096,000 | 507,092,000 | 494,806,000 | 486,014,000 | 476,001,000 | 471,477,000 | 469,283,000 | 464,812,000 | 460,235,000 | 374,386,000 | 370,561,000 | 271,394,000 | 269,582,000 | 268,822,000 |
| accumulated other comprehensive income | 293,000 | -202,000 | -7,000 | 10,000 | 16,000 | 9,000 | 21,000 | 103,000 | 35,000 | 57,000 | 75,000 | |||||||||
| retained earnings | 110,465,000 | 66,160,000 | 31,174,000 | 2,312,000 | ||||||||||||||||
| total stockholders’ equity | 668,677,000 | 601,245,000 | 616,912,000 | 570,687,000 | 511,316,000 | 355,930,000 | 305,068,000 | 267,823,000 | 241,830,000 | 220,291,000 | 208,347,000 | 204,254,000 | 225,654,000 | 237,047,000 | 245,423,000 | 177,772,000 | 192,653,000 | 108,250,000 | 119,413,000 | 129,186,000 |
| total liabilities and stockholders’ equity | 1,566,563,000 | 1,473,959,000 | 786,604,000 | 783,247,000 | 646,089,000 | 475,809,000 | 417,145,000 | 372,520,000 | 345,682,000 | 298,995,000 | 276,359,000 | 269,070,000 | 272,042,000 | 280,658,000 | 287,353,000 | 220,738,000 | ||||
| preferred stock | ||||||||||||||||||||
| accumulated other comprehensive loss | -149,000 | -391,000 | -367,000 | -867,000 | -1,612,000 | -1,337,000 | -1,017,000 | |||||||||||||
| debt, current portion | 80,000,000 | |||||||||||||||||||
| preferred stock, 0.001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of december 31, 2022 and 2021 | ||||||||||||||||||||
| accumulated deficit | -36,813,000 | -177,724,000 | -212,727,000 | -238,288,000 | -252,809,000 | -265,751,000 | -267,699,000 | -267,274,000 | -243,673,000 | -227,799,000 | -214,867,000 | -196,749,000 | -177,974,000 | -163,229,000 | -150,272,000 | -139,664,000 | ||||
| term notes, current portion | 11,000,000 | 8,250,000 | 5,500,000 | 2,750,000 | 4,125,000 | 4,950,000 | 3,300,000 | 1,650,000 | 6,667,000 | 6,667,000 | 5,000,000 | 3,333,000 | ||||||||
| term notes, noncurrent portion | 14,853,000 | 6,440,000 | 9,033,000 | 11,630,000 | 14,226,000 | 12,833,000 | 11,836,000 | 13,319,000 | 14,801,000 | 16,286,000 | 16,126,000 | 7,152,000 | 8,705,000 | 10,262,000 | 11,821,000 | |||||
| preferred stock, 0.001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of december 31, 2021 and 2020 | ||||||||||||||||||||
| preferred stock, 0.001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of december 31, 2020 and 2019 | ||||||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ equity | ||||||||||||||||||||
| convertible preferred stock warrant liability | ||||||||||||||||||||
| convertible preferred stock, 0.001 par value; 5,000,000 and 229,098,987 shares authorized as of december 31, 2019 and 2018; nil and 18,670,328 shares issued and outstanding as of december 31, 2019 and 2018 | ||||||||||||||||||||
| stockholders’ equity | ||||||||||||||||||||
| total liabilities, convertible preferred stock and stockholders’ equity | 231,938,000 | 137,889,000 | 146,807,000 | 157,539,000 | ||||||||||||||||
| convertible preferred stock |
We provide you with 20 years of balance sheets for ShockWave Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ShockWave Medical. Explore the full financial landscape of ShockWave Medical stock with our expertly curated balance sheets.
The information provided in this report about ShockWave Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.